{
  "created_at": "Tue Jul 27 7:59:1 +0000 2021",
  "id_str": "1419907938773356553",
  "full_text": "BioNTech said it would invest some of the profits from the Covid-19 vaccine it markets with Pfizer into developing shots for malaria and tuberculosis in Africa, part of the company’s plan to establish a production hub for innovative medicines https://t.co/7UcHMk7Vqc",
  "display_text_range": [
    0,
    266
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/7UcHMk7Vqc",
        "expanded_url": "https://on.wsj.com/3iUv6Yg",
        "display_url": "on.wsj.com/3iUv6Yg",
        "indices": [
          243,
          266
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 26,
  "favorite_count": 99,
  "possibly_sensitive": false,
  "original_created_at": "Tue Jul 27 06:30:07 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "バイオンテック社は、ファイザー社と共同で販売しているCovid-19ワクチンの利益の一部を、アフリカでのマラリアや結核の予防接種の開発に投資し、革新的な医薬品の生産拠点を設立する計画を発表しました。https://t.co/7UcHMk7Vqc"
    },
    {
      "locale": "zh",
      "full_text": "BioNTech表示，它将把与辉瑞公司合作销售的Covid-19疫苗的部分利润投入到开发非洲的疟疾和结核病疫苗中，这是公司建立创新药物生产中心计划的一部分https://t.co/7UcHMk7Vqc。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "BioNTech表示，它將把與輝瑞公司合作銷售的Covid-19疫苗的部分利潤投入到開發非洲的瘧疾和結核病疫苗中，這是公司建立創新藥物生產中心計劃的一部分https://t.co/7UcHMk7Vqc。"
    }
  ]
}